Use of prothymosin in the diagnosis and treatment of endometriosis
US6753138B1 · kind B1 · utility
13Cited by
2References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 27, 2000 |
| Grant date | Jun 22, 2004 |
| Priority date | — |
| Expiry date | Dec 27, 2020 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/364
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Prothymosin expression is up-regulated in endometriotic tissue. This invention provides methods of diagnosing endometriosis by detecting up-regulation of a prothymosin gene product, and methods of treating endometriosis by down-regulating expression of prothymosin in ectopic or eutopic endometriotic tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.